Pfizer CEO Albert Bourla said Thursday that a third dose of the company’s COVID-19 vaccine was “likely” to be needed within a year of the initial two-dose inoculation
A plurality of respondents, 46%, answered they would get the shot as soon as it was available to them, but 31% of respondents said they do not plan to get it
The CDC called its advisers together Wednesday for a public debate about how to handle the J&J vaccine while authorities nail down exactly what’s happening.
Lena H. Sun, The Washington Post and Carolyn Y. Johnson, The Washington Post
Something went wrong. Please try again in a few minutes. If the problem persists, please contact customer service at 800-228-6397 or pgsupport@post-gazette.com.